Doing More with Less
Dwindling federal reimbursements are expected to play a significant role: by 2023, reimbursements for some common laboratory tests may be slashed by 15 percent in that year, and that鈥檚 on top of the 10 percent cut in 2020.
The cuts mandated by the Protecting Access to Medicare Act may result in the loss of millions of dollars in annual revenue for some large health systems, and this was all before COVID-19 began devastating the balance sheets of hospitals and health systems across the United States.
This white paper provides an overview of some of the revenue challenges hospitals and health systems face today as well as detailing cost reduction strategies they can implement that maintain quality and safety in the laboratory.